Market Overview

UPDATE: Deutsche Bank Raises PT to $29 on Team Health on Revenue Visibility

Related TMH
TeamHealth Acquires Premier Physician Services
Team Health Holdings, Inc. Completes Amendment and Restatement of Existing Credit Facility

Deutsche Bank reiterated its Buy rating on Team Health (NYSE: TMH) and raised its price target from $26 to $29.

Deutsche Bank noted, "We expect another strong quarter, driven by top-line growth that should remain balanced b/w organic (same-contract), new contract sales and contributions from M&A. In light of strong rev growth visibility, we are raising our PT to $29 (from $26) and now put the fwd EV/EBITDA at the upper end of the group's historical 8x-9x range."

Team Health closed at $26.94 on Monday.

Latest Ratings for TMH

Sep 2014Stifel NicolausMaintainsBuy
Sep 2014Deutsche BankMaintainsHold
Aug 2014Deutsche BankUpgradesBuyHold

View More Analyst Ratings for TMH
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Price Target Intraday Update Analyst Ratings


Related Articles (TMH)

Around the Web, We're Loving...

Get Benzinga's Newsletters